πŸ‡ΊπŸ‡Έ FDA
Patent

US 7723022

Immunostimulatory nucleic acid molecules

granted A61KA61K2039/55561A61K31/00

Quick answer

US patent 7723022 (Immunostimulatory nucleic acid molecules) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/55561, A61K31/00, A61K31/4706, A61K31/7048